Quarterly report · Q2
4078.TEDINET S100PH2A
Period2022-04-01 → 2022-09-30
Filed2022-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥42.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥80.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥39.9bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥3.3bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥4.4bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥3.8bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥8.8bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.6bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥4.5bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.7bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥3.3bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥128.4bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥123.9bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥124.5bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥42.6bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥41.2bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥85.8bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥82.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥82.3bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.9bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.8bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥11.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.8bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.2bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.7bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.0bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥177.48 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.08 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥407.06 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥188.85 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥91.63 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 63.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.2% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥860m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥860m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥1.1bn |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥39.3bn |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥38.6bn |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥697m |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.2bn |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥163m |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥240m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥43.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥42.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥860m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥684m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥684m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥977m |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥36.4bn |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥35.8bn |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥548m |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥5.1bn |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥4.2bn |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥136m |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥233m |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥40.6bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥39.9bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥684m |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥5.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 510
| Item | Context | Value | Unit |
|---|---|---|---|
| Selling general and administrative expenses | Prior1YTDDuration | 6606000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 7115000000 | JPY |
| Operating income | Prior1YTDDuration | 4356000000 | JPY |
| Operating income | CurrentYTDDuration | 3267000000 | JPY |
| Interest income noi | Prior1YTDDuration | 4000000 | JPY |
| Interest income noi | CurrentYTDDuration | 2000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 116000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 90000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 131000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | 497000000 | JPY |
| Other noi | Prior1YTDDuration | 93000000 | JPY |
| Other noi | CurrentYTDDuration | 42000000 | JPY |
| Non operating income | Prior1YTDDuration | 346000000 | JPY |
| Non operating income | CurrentYTDDuration | 632000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 37000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 36000000 | JPY |
| Other noe | Prior1YTDDuration | 65000000 | JPY |
| Other noe | CurrentYTDDuration | 33000000 | JPY |
| Non operating expenses | Prior1YTDDuration | 103000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 69000000 | JPY |
| Ordinary income | Prior1YTDDuration | 4599000000 | JPY |
| Ordinary income | CurrentYTDDuration | 3830000000 | JPY |
| Gain on sales of noncurrent assets ei | Prior1YTDDuration | 1000000 | JPY |
| Gain on sales of noncurrent assets ei | CurrentYTDDuration | 1000000 | JPY |
| Gain on sales of investment securities ei | Prior1YTDDuration | 90000000 | JPY |
| Gain on sales of investment securities ei | CurrentYTDDuration | 79000000 | JPY |
| Gain on sales of golf memberships ei | Prior1YTDDuration | － | JPY |
| Gain on sales of golf memberships ei | CurrentYTDDuration | 1000000 | JPY |
| Insurance income ei | Prior1YTDDuration | － | JPY |
| Insurance income ei | CurrentYTDDuration | 379000000 | JPY |
| Extraordinary income | Prior1YTDDuration | 92000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 461000000 | JPY |
| Loss on explosion and fire accident el | Prior1YTDDuration | 143000000 | JPY |
| Loss on explosion and fire accident el | CurrentYTDDuration | － | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 11000000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 72000000 | JPY |
| Loss on valuation of investment securities el | Prior1YTDDuration | 0 | JPY |
| Loss on valuation of investment securities el | CurrentYTDDuration | － | JPY |
| Other el | Prior1YTDDuration | － | JPY |
| Other el | CurrentYTDDuration | 0 | JPY |
| Extraordinary loss | Prior1YTDDuration | 154000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 72000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 4537000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 4218000000 | JPY |
| Income taxes | Prior1YTDDuration | 1201000000 | JPY |
| Income taxes | CurrentYTDDuration | 1195000000 | JPY |
| Profit loss | Prior1YTDDuration | 3336000000 | JPY |
| Profit loss | CurrentYTDDuration | 3023000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 155000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 151000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |